To Infinity and Beyond: Scaling AI Across a Global Organization

In 2020, Pfizer began a ground-breaking partnership with Saama to automate their data review processes with artificial intelligence. The result was Smart Data Quality (SDQ), which significantly cut down their time to database lock, and allowed Pfizer to reach the market with their COVID-19 vaccine at lightning speed.

But how has the partnership evolved since then? What impact has Pfizer seen from deploying these AI-driven solutions across their organization? And what innovative applications of AI are they working on next?

Come hear from Prasanna Rao, Senior Director, Global Head of AI/ML at Pfizer and Lisa Moneymaker, Chief Technology Officer and Chief Product Officer at Saama, about:

-How Pfizer is scaling Saama’s AI-driven platform across their clinical development organization

-The impact to time, quality and cost Pfizer has realized from SDQ

-How Saama and Pfizer are applying generative AI to key clinical development processes

-Saama’s approach to integrating AI into existing application workflows, making it easier to deploy within any organization